Cargando…
Risk Factors Associated with Sexually Transmitted Infections among Pre-Exposure Prophylaxis Users in an Urban Multi-Clinic Healthcare System
BACKGROUND: While the efficacy of Pre-Exposure Prophylaxis (PrEP) in the prevention of HIV is well established in clinical trials, its utility in clinical practice needs to be defined. In contrast to lifelong HIV treatment, the use of PrEP should be only for those who remain at continued risk of HIV...
Autores principales: | Abrams-Downey, Alexandra, Ventuneac, Ana, Duah, Bianca, Aracena, Joaquin, Arroyo, Hansel, Aberg, Judith, Cespedes, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630945/ http://dx.doi.org/10.1093/ofid/ofx163.1785 |
Ejemplares similares
-
860. Immediate Access to Post-Exposure Prophylaxis (PEP) Through a 24/7 New York City PEP Hotline
por: Glaser, Allison, et al.
Publicado: (2018) -
Missed opportunities for sexually transmitted infections testing for HIV pre‐exposure prophylaxis users: a systematic review
por: Ong, Jason J, et al.
Publicado: (2021) -
The impact of HIV pre-exposure prophylaxis on sexually transmitted infections incidence in Bulgaria
por: Pakov, I, et al.
Publicado: (2023) -
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections
por: Grant, Juliana S, et al.
Publicado: (2020) -
1495. Incidence of Sexually Transmitted Infections (STIs) in Patients on Pre-exposure Prophylaxis (PrEP)
por: Hamed, Almutase, et al.
Publicado: (2018)